These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37154105)

  • 1. Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/β-catenin pathway in cervical cancer.
    Yang G; He Y; Chen Y; Huang Z; Huang J; Ren X; Xu S; Li P
    Drug Dev Res; 2023 Sep; 84(6):1114-1126. PubMed ID: 37154105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study.
    Bai D; Yu S; Zhong S; Zhao B; Qiu S; Chen J; Lunagariya J; Liao X; Xu S
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Hsu W; Liu L; Chen X; Zhang Y; Zhu W
    Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway.
    Dai B; Yang T; Shi X; Ma N; Kang Y; Zhang J; Zhang Y
    Phytomedicine; 2018 Dec; 51():48-57. PubMed ID: 30466627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway.
    Zhang J; Zhang C; Sang L; Huang L; Du J; Zhao X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30249755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
    Li L; Yang WT; Zheng PS; Liu XF
    Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galaxamide alleviates cisplatin-induced premature ovarian insufficiency via the PI3K signaling pathway in HeLa tumor-bearing mice.
    Tao H; Chen Z; Yao B; Ren X; Shuai H; Xu S; Zha Q; Li P
    BMC Cancer; 2024 Aug; 24(1):1060. PubMed ID: 39192214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
    Zhang X; Wang M; Zhang Y; Yang J; Duan W
    Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemness.
    Xie X; Chen J; Wo D; Ma E; Ning Y; Peng J; Zhu W; Ren DN
    J Ethnopharmacol; 2021 Nov; 280():114449. PubMed ID: 34332067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sdy-1 Executes Antitumor Activity in HepG2 and HeLa Cancer Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
    Sun M; Zhou D; Wu J; Zhou J; Xu J
    Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.
    Xu Y; Hu J; Lv Q; Shi C; Qiu M; Xie L; Liu W; Yang B; Shan W; Cheng Y; Zhao B; Chen X
    Stem Cell Res Ther; 2023 Jun; 14(1):159. PubMed ID: 37287079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
    Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6
    Feng Q; Li S; Ma HM; Yang WT; Zheng PS
    Oncogene; 2021 Oct; 40(42):6103-6114. PubMed ID: 34489551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, cytotoxicity and apoptosis induction in human tumor cells by galaxamide and its analogues [corrected].
    Xiao X; Liao X; Qiu S; Liu Z; Du B; Xu S
    Mar Drugs; 2014 Aug; 12(8):4521-38. PubMed ID: 25231922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation.
    Li J; Fang R; Wu J; Si Y; Bai J; Wang Q
    Bioengineered; 2022 Mar; 13(3):7648-7658. PubMed ID: 35282769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.